Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Price & Market Data

Price: $342.3

Daily Change: +$4.18 / 1.22%

Daily Range: $333.2 - $346.5

Market Cap: $7,629,301,760

Daily Volume: 381,284

Performance Metrics

1 Week: 13.15%

1 Month: 10.92%

3 Months: 14.54%

6 Months: 0.68%

1 Year: 31.93%

YTD: 10.93%

Company Details

Employees: 528

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

Hovnanian Enterprises, Inc. (HOV)

Legacy Housing Corporation (LEGH)

Imax Corporation (IMAX)